Spots Global Cancer Trial Database for IBD Neoplasia Surveillance RCT
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: IBD Neoplasia Surveillance RCT
Official Title: A Randomized Controlled Non-Inferiority Trial Comparing Neoplasia Detection During Colonoscopy Screening With and Without Non-Targeted Biopsies in Adult Colonic Inflammatory Bowel Disease
Study ID: NCT05809999
Interventions
Study Description
Brief Summary: We will conduct a multicenter, parallel-group, non-inferiority RCT in persons with IBD undergoing colorectal neoplasia screening with high-definition white light colonoscopy, comparing a strategy of sampling visible lesions alone to a conventional strategy of sampling both visible lesions as well as normal-appearing mucosa using non-targeted biopsies. The primary outcome is the neoplasia detection rate. The required sample size to demonstrate non-inferiority is 1952 persons.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of Alberta, Edmonton, Alberta, Canada
St. Paul's Hospital, Vancouver, British Columbia, Canada
University of Manitoba, Health Sciences Centre, Winnipeg, Manitoba, Canada
Eastern Regional Health Authority, St. John's, NFLD, Canada
Nova Scotia Health Authority, Halifax, Nova Scotia, Canada
Hamilton Health Sciences, Hamilton, Ontario, Canada
London Health Sciences Centre, University Hospital, London, Ontario, Canada
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
Thunder Bay Regional Health Sciences Centre, Thunder Bay, Ontario, Canada
Mount Sinai Hospital, Toronto, Ontario, Canada
McGill University Health Centre, Montreal, Quebec, Canada
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
